Latest issue of Barrons mentioned GBH selling at 27% discount to NAV. Infact it was recommened to sell HQL and buy HQH or sell both and buy GBH,which has 43% of portfolio in biotech. I am going to continue to hold HQL and buy GBH as well.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat